Hjem › Medulloblastom › Michigan
Medulloblastom kliniske forsøg i Michigan
4 studier for Medulloblastom søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- C.S. MOTT Children's Hospital, University of Michigan, Ann Arbor
RekruttererFase 2
59 Months · Alle køn · Opdateret 15. sep. 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Helen DeVos Children's Hospital, Grand Rapids
RekruttererFase 2
Op til 19 år · Alle køn · Opdateret 10. sep. 2026 · NCT01356290A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- og 1 flere
RekruttererFase 3
Alder 4 til 21 · Alle køn · Opdateret 25. aug. 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2
Alder 3 til 39 · Alle køn · Opdateret 24. aug. 2026 · NCT05096481Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.